HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $20
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and raises the price target from $2 to $20.
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and raises the price target from $2 to $20.